Skip to main content
Caplight Logo









Amferia

Amferia

Private
MölndalHealthcare & Life Scienceshttps://www.amferia.com/

Last Round

VC Round

Dec 15, 2025

Total Funding Raised

$1.12M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Amferia is a therapeutic devices company that develops and markets medical devices with an emphasis on antibacterial products that effectively kill bacteria in applications such as wound care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

antimicrobial coatinginfection preventionmedical device coatinghospital-acquired infectionsHAIsbiofilm preventionantimicrobial hydrogelwound carecatheter-associated urinary tract infectionsCAUTIantimicrobial peptidesantibiotic resistanceinfection controlsuperbugsmedtechadvanced materials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amferia Comparables

Compare Amferia with similar companies based on industry and business-model similarity.

Amferia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LipoCoat
82%
Silq Technologies
80%
Allvivo Vascular
78%

Amferia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 15, 2025
VC RoundSep 3, 2024
GrantMar 26, 2024
VC RoundJan 27, 2023
SeedJan 22, 2020
Seed
Sep 1, 2018

Key People

Founding team and executive leadership

Anand Kumar Rajasekharan

CEO Co-Founder

Founding Team

Daniel Hagberg

CTO

Executive Team

Ingvar Karlsson

Chief Financial Officer

Executive Team

Amferia Investors

Notable investors and investment history

Amferia investors
InvestorRounds
Eurostars SME programmeGrant
Almi Invest ABVC Round, Seed
VinnovaGrant
Chalmers VenturesSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2026

    Monthly visitors grew 387% MoM, from 347 to 1.7K.

  • Dec 15, 2025

    $4.1M raised in a VC Round.

Amferia Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amferia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amferia's valuation, stock price, and market status.

Firmographic Details

HeadquartersMölndal
Employee Range18
Year Founded2018
Last FundingDec 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?